MediWound Ltd.
MDWD
$17.40
$0.070.40%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 8.22% | -21.01% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 8.22% | -21.01% | |
| Cost of Revenue | -- | -- | 16.42% | 23.81% | |
| Gross Profit | -- | -- | -26.38% | -77.76% | |
| SG&A Expenses | -- | -- | 13.14% | 1.26% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | 200.00% | |
| Total Operating Expenses | -- | -- | 15.90% | 10.29% | |
| Operating Income | -- | -- | -25.15% | -100.21% | |
| Income Before Tax | -- | -- | -361.84% | -126.80% | |
| Income Tax Expenses | -- | -- | -67.03% | 25.38% | |
| Earnings from Continuing Operations | -- | -- | -350.03% | -125.74% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -350.03% | -125.74% | |
| EBIT | -- | -- | -25.15% | -100.21% | |
| EBITDA | -- | -- | -26.23% | -113.61% | |
| EPS Basic | -- | -- | -300.20% | -65.12% | |
| Normalized Basic EPS | -- | -- | -4.08% | -95.26% | |
| EPS Diluted | -- | -- | -300.20% | -65.12% | |
| Normalized Diluted EPS | -- | -- | -4.08% | -95.26% | |
| Average Basic Shares Outstanding | -- | -- | 10.49% | 15.38% | |
| Average Diluted Shares Outstanding | -- | -- | 10.49% | 15.38% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |